{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:35:06Z","timestamp":1787589306431,"version":"build-2736575974"},"posted":{"date-parts":[[2026,1,15]]},"group-title":"Addiction Medicine","reference-count":76,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Gabapentin and pregabalin have potential utility for treating alcohol use disorder (AUD), but their comparative effectiveness in reducing alcohol consumption in real-world settings is unknown. We compared changes in alcohol consumption associated with gabapentin or pregabalin treatment with those of matched unexposed comparators.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We identified patients who were prescribed gabapentin or pregabalin for \u226560 days for any indication between 1 January 2009 and 30 June 2022 using electronic health records from the Veterans Aging Cohort Study (VACS-National). Alcohol consumption was measured using routinely-collected Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) questionnaires. We used propensity score matching to balance baseline characteristics between groups. Three comparisons were conducted: gabapentin vs. unexposed, pregabalin vs. unexposed, and pregabalin vs. gabapentin. Changes in AUDIT-C scores were estimated using multivariable difference-in-difference linear regression models. Analyses were stratified by baseline AUD diagnosis and AUDIT-C categories (lower-risk, at-risk, hazardous\/binge).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 592,957 gabapentin initiators, 14,923 pregabalin initiators, and 2,959,006 eligible unexposed comparators who were eligible for matching. Compared to unexposed individuals, patients who received gabapentin (DiD: 0.09, 95% CI 0.06, 0.11, p&lt;0.0001) or pregabalin (DiD: 0.14, 95% CI 0.02, 0.26, p=0.0279) reported greater reductions in AUDIT-C scores. When compared head-to-head, pregabalin initiators reported greater reductions in AUDIT-C scores than gabapentin initiators with the largest difference observed among those with AUD (DiD: 0.86, 95% CI 1.22, 0.50, p&lt;0.0001) and those who report baseline hazardous\/binge drinking (DiD: 1.74, 95% CI 2.21, 1.27, p&lt;0.0001).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>In this large, nationwide cohort, treatment with gabapentin and pregabalin were associated with reductions in reported alcohol consumption, compared to matched unexposed comparators. Initiation of pregabalin was associated with greater reductions than with gabapentin, particularly among those with AUD and those with highest severity of alcohol use. Known safety concerns and risk of misuse should be considered when prescribing these medications. Randomized clinical trials directly comparing these medications are necessary to validate these findings.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.01.13.26344031","type":"posted-content","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T16:20:12Z","timestamp":1768494012000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparative effectiveness of gabapentin and pregabalin on reduction in alcohol use: A nationwide observational cohort study"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-2829","authenticated-orcid":false,"given":"Tommy","family":"Gunawan","sequence":"first","affiliation":[{"name":"Uniformed Services University, Bethesda, MD, 20814, US"},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-561X","authenticated-orcid":false,"given":"Joshua C.","family":"Gray","sequence":"additional","affiliation":[{"name":"Uniformed Services University, Bethesda, MD, 20814, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Shi","sequence":"additional","affiliation":[{"name":"Uniformed Services University, Bethesda, MD, 20814, US"},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wingo","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, UC Davis, Sacramento, CA 95825"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza P.","family":"Wingo","sequence":"additional","affiliation":[{"name":"VA Northern California Health Care System and Department of Psychiatry and Behavioral Services, School of Medicine, UC Davis, Sacramento, CA 95817"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, 06511, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tazare","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Farokhnia","sequence":"additional","affiliation":[{"name":"Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, NIH, Baltimore and Bethesda, MD, US"},{"name":"Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[{"name":"Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, NIH, Baltimore and Bethesda, MD, US"},{"name":"Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence, RI 02912, US"},{"name":"Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, US"},{"name":"Department of Neuroscience, Georgetown University Medical Center, Washington, DC 20057, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Kranzler","sequence":"additional","affiliation":[{"name":"Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine and Crescenz Veterans Affairs Medical Center, Philadelphia, PA, 19104, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-7907","authenticated-orcid":false,"given":"Christopher T.","family":"Rentsch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, 06511, US"},{"name":"Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK"},{"name":"VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, 06516, US"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026011900300995000_2026.01.13.26344031v1.1","unstructured":"World Health Organization. Global status report on alcohol and health and treatment of substance use disorders. June 25, 2024. Accessed September 24, 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240096745"},{"key":"2026011900300995000_2026.01.13.26344031v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.05.031"},{"key":"2026011900300995000_2026.01.13.26344031v1.3","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) C for BHS and Q (CBHSQ). 2024 National Survey on Drug Use and Health. August 6, 2025. Accessed December 11, 2025. https:\/\/www.samhsa.gov\/data\/report\/2024-nsduh-detailed-tables"},{"key":"2026011900300995000_2026.01.13.26344031v1.4","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.AAX4043"},{"key":"2026011900300995000_2026.01.13.26344031v1.5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.1750101"},{"key":"2026011900300995000_2026.01.13.26344031v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.11406"},{"key":"2026011900300995000_2026.01.13.26344031v1.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19761"},{"issue":"6","key":"2026011900300995000_2026.01.13.26344031v1.8","first-page":"457","article-title":"Medications for Alcohol Use Disorder","volume":"93","year":"2016","journal-title":"Am Fam Physician"},{"key":"2026011900300995000_2026.01.13.26344031v1.9","doi-asserted-by":"publisher","DOI":"10.1111\/ACER.15118"},{"key":"2026011900300995000_2026.01.13.26344031v1.10","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1133472"},{"key":"2026011900300995000_2026.01.13.26344031v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.04.032"},{"key":"2026011900300995000_2026.01.13.26344031v1.12","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1349098"},{"key":"2026011900300995000_2026.01.13.26344031v1.13","doi-asserted-by":"publisher","DOI":"10.1097\/hrp.0000000000000079"},{"key":"2026011900300995000_2026.01.13.26344031v1.14","doi-asserted-by":"publisher","DOI":"10.64898\/2026.01.09.26343615"},{"key":"2026011900300995000_2026.01.13.26344031v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/S41588-025-02291-2"},{"key":"2026011900300995000_2026.01.13.26344031v1.16","doi-asserted-by":"publisher","DOI":"10.1007\/S40122-017-0087-0"},{"key":"2026011900300995000_2026.01.13.26344031v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2016.01.017"},{"key":"2026011900300995000_2026.01.13.26344031v1.18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005755"},{"key":"2026011900300995000_2026.01.13.26344031v1.19","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2022.927703\/FULL"},{"key":"2026011900300995000_2026.01.13.26344031v1.20","doi-asserted-by":"publisher","DOI":"10.1111\/add.14655"},{"key":"2026011900300995000_2026.01.13.26344031v1.21","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2016.1202764"},{"key":"2026011900300995000_2026.01.13.26344031v1.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2008.00133.x"},{"key":"2026011900300995000_2026.01.13.26344031v1.23","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAINTERNMED.2020.0249"},{"key":"2026011900300995000_2026.01.13.26344031v1.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2008.00706.x"},{"key":"2026011900300995000_2026.01.13.26344031v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2018.09.002"},{"key":"2026011900300995000_2026.01.13.26344031v1.26","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1108"},{"key":"2026011900300995000_2026.01.13.26344031v1.27","doi-asserted-by":"publisher","DOI":"10.1111\/ACER.14648"},{"key":"2026011900300995000_2026.01.13.26344031v1.28","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAINTERNMED.2013.11950"},{"key":"2026011900300995000_2026.01.13.26344031v1.29","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13917"},{"key":"2026011900300995000_2026.01.13.26344031v1.30","doi-asserted-by":"publisher","DOI":"10.1097\/ADT.0b013e31812e6a3c"},{"issue":"3","key":"2026011900300995000_2026.01.13.26344031v1.31","first-page":"226","article-title":"Diabetic Peripheral Neuropathy: Prevention and Treatment","volume":"109","year":"2024","journal-title":"Am Fam Physician"},{"key":"2026011900300995000_2026.01.13.26344031v1.32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011790.PUB2"},{"key":"2026011900300995000_2026.01.13.26344031v1.33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000119"},{"key":"2026011900300995000_2026.01.13.26344031v1.34","doi-asserted-by":"publisher","DOI":"10.1007\/S40122-021-00302-8"},{"key":"2026011900300995000_2026.01.13.26344031v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1098"},{"key":"2026011900300995000_2026.01.13.26344031v1.36","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2021.1901105"},{"key":"2026011900300995000_2026.01.13.26344031v1.37","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-008-0066-2"},{"key":"2026011900300995000_2026.01.13.26344031v1.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02792.x"},{"key":"2026011900300995000_2026.01.13.26344031v1.39","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agr153"},{"key":"2026011900300995000_2026.01.13.26344031v1.40","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109102623"},{"key":"2026011900300995000_2026.01.13.26344031v1.41","doi-asserted-by":"publisher","DOI":"10.2165\/11536200-000000000-00000"},{"key":"2026011900300995000_2026.01.13.26344031v1.42","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01432-7"},{"key":"2026011900300995000_2026.01.13.26344031v1.43","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07314-2"},{"key":"2026011900300995000_2026.01.13.26344031v1.44","unstructured":"NHS England. Handling of gabapentin and pregabalin as schedule 3 controlled drugs in health and justice commissioned services. January 1, 2019. Accessed October 20, 2025. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/02\/handling-pregabalin-and-gabapentin.pdf"},{"key":"2026011900300995000_2026.01.13.26344031v1.45","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.93.7.1137"},{"key":"2026011900300995000_2026.01.13.26344031v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2026011900300995000_2026.01.13.26344031v1.47","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"2026011900300995000_2026.01.13.26344031v1.48","doi-asserted-by":"publisher","DOI":"10.1089\/AID.2019.0136"},{"key":"2026011900300995000_2026.01.13.26344031v1.49","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835b8c7f"},{"key":"2026011900300995000_2026.01.13.26344031v1.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00403.x"},{"key":"2026011900300995000_2026.01.13.26344031v1.51","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.16.1789"},{"key":"2026011900300995000_2026.01.13.26344031v1.52","doi-asserted-by":"publisher","DOI":"10.1111\/ADD.13505"},{"key":"2026011900300995000_2026.01.13.26344031v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109821"},{"key":"2026011900300995000_2026.01.13.26344031v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2016.01.017"},{"key":"2026011900300995000_2026.01.13.26344031v1.55","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8503"},{"key":"2026011900300995000_2026.01.13.26344031v1.56","doi-asserted-by":"publisher","DOI":"10.2307\/2669455"},{"key":"2026011900300995000_2026.01.13.26344031v1.57","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"2026011900300995000_2026.01.13.26344031v1.58","doi-asserted-by":"publisher","DOI":"10.1162\/rest.89.2.221"},{"key":"2026011900300995000_2026.01.13.26344031v1.59","doi-asserted-by":"publisher","DOI":"10.1561\/0800000014"},{"key":"2026011900300995000_2026.01.13.26344031v1.60","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13953"},{"key":"2026011900300995000_2026.01.13.26344031v1.61","doi-asserted-by":"publisher","DOI":"10.1093\/ALCALC\/AGAF010"},{"key":"2026011900300995000_2026.01.13.26344031v1.62","doi-asserted-by":"publisher","DOI":"10.1111\/ACER.14414"},{"key":"2026011900300995000_2026.01.13.26344031v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.14"},{"key":"2026011900300995000_2026.01.13.26344031v1.64","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001316"},{"key":"2026011900300995000_2026.01.13.26344031v1.65","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1417383"},{"key":"2026011900300995000_2026.01.13.26344031v1.66","doi-asserted-by":"publisher","DOI":"10.1016\/J.PBB.2022.173482"},{"key":"2026011900300995000_2026.01.13.26344031v1.67","doi-asserted-by":"publisher","DOI":"10.1177\/1178221818801311"},{"key":"2026011900300995000_2026.01.13.26344031v1.68","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14408"},{"key":"2026011900300995000_2026.01.13.26344031v1.69","doi-asserted-by":"publisher","DOI":"10.1172\/JCI188314"},{"key":"2026011900300995000_2026.01.13.26344031v1.70","doi-asserted-by":"publisher","DOI":"10.1038\/S41380-022-01736-Y"},{"key":"2026011900300995000_2026.01.13.26344031v1.71","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10101436"},{"key":"2026011900300995000_2026.01.13.26344031v1.72","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172889"},{"key":"2026011900300995000_2026.01.13.26344031v1.73","doi-asserted-by":"publisher","DOI":"10.1111\/JOIM.70021"},{"key":"2026011900300995000_2026.01.13.26344031v1.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2012.07.029"},{"key":"2026011900300995000_2026.01.13.26344031v1.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2012.01.006"},{"key":"2026011900300995000_2026.01.13.26344031v1.76","doi-asserted-by":"publisher","DOI":"10.7249\/rr1165.1"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.13.26344031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:30:21Z","timestamp":1768811421000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.01.13.26344031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":76,"URL":"https:\/\/doi.org\/10.64898\/2026.01.13.26344031","relation":{},"subject":[],"published":{"date-parts":[[2026,1,15]]},"subtype":"preprint"}}